Last mentioned: 1d ago
Social media trends drive a surge in requests for surgical remains to be converted into keepsakes.
Medical journals increase focus on the lack of regulation in the placenta encapsulation industry.
The Conversation publishes a comprehensive analysis of the risks associated with human tissue keepsakes.
Dual-Leadership Confirmed
International sources confirm Bhattacharya will lead both agencies, highlighting the strategic consolidation of health oversight.
CDC Appointment Announced
Reports emerge that NIH Director Dr. Jay Bhattacharya will take over as acting head of the CDC.
CDC Warning Issued
The CDC issues a formal warning after a newborn develops sepsis from maternal placenta consumption.
Preliminary reports from US health officials indicate that this season's influenza vaccines provided lower-than-expected protection against circulating strains. The findings underscore the persistent challenge of viral mismatch and are expected to accelerate the industry's shift toward next-generation mRNA and recombinant vaccine technologies.
The CDC has issued urgent travel advisories for several popular tourist destinations following a confirmed spread of poliovirus. This development signals a significant setback for global eradication efforts and is expected to drive a surge in demand for inactivated poliovirus vaccines (IPV).
A growing trend of retaining and consuming human tissue, such as placentas and surgical remains, is raising significant biohazard and infection concerns. Medical experts warn that the lack of regulatory oversight and clinical evidence for these practices poses serious risks to public health.
The United States and the Democratic Republic of the Congo have finalized a $1.2 billion health partnership aimed at strengthening healthcare infrastructure and disease surveillance. This multi-year commitment focuses on global health security, infectious disease control, and improving maternal and child health outcomes.
NIH Director Dr. Jay Bhattacharya has been appointed as the acting head of the CDC, creating a historic dual-leadership role over the two most powerful U.S. health agencies. This consolidation marks a significant shift in public health strategy, placing research and implementation under a single executive.